Myriad Genetics, Inc. (MYGN)
4.28
-0.34
(-7.36%)
USD |
NASDAQ |
Mar 27, 16:00
4.28
0.00 (0.00%)
After-Hours: 20:00
Myriad Genetics Debt to Equity Ratio : 0.5701 for Dec. 31, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Abbott Laboratories | 0.2712 |
| Insulet Corp. | 0.6612 |
| Pacific Biosciences of California, Inc. | 131.32 |
| Tandem Diabetes Care, Inc. | 2.896 |
| iRhythm Holdings, Inc. | 4.787 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 706.60M |
| Total Liabilities (Quarterly) | 338.60M |
| Shareholders Equity (Quarterly) | 368.00M |
| Current Ratio | 2.486 |
| Net Debt Paydown Yield | -2.32% |